Pathogenesis of systemic lupus erythematosus

被引:600
作者
Mok, CC
Lau, CS
机构
[1] Tuen Mun Hosp, Dept Med & Geriatr, New Terr, Hong Kong, Peoples R China
[2] Queen Mary Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China
关键词
D O I
10.1136/jcp.56.7.481
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The exact patho-aetiology of systemic lupus erythematosus (SLE) remains elusive. An extremely complicated and multifactorial interaction among various genetic and environmental factors is probably involved. Multiple genes contribute to disease susceptibility. The interaction of sex, hormonal milieu, and the hypothalamo-pituitary-adrenal axis modifies this susceptibility and the clinical expression of the disease. Defective immune regulatory mechanisms, such as the clearance of apoptotic cells and immune complexes, are important contributors to the development of SLE. The loss of immune tolerance, increased antigenic load, excess T cell help, defective B cell suppression, and the shifting of T helper 1 (Th1) to Th2 immune responses leads to B cell hyperactivity and the production of pathogenic autoantibodies. Finally, certain environmental factors are probably required to trigger the disease.
引用
收藏
页码:481 / 490
页数:10
相关论文
共 156 条
[1]   ROLE OF GENETIC-FACTORS IN DRUG-RELATED AUTOIMMUNITY [J].
ADAMS, LE ;
MONGEY, AB .
LUPUS, 1994, 3 (06) :443-447
[2]   Gender and risk of autoimmune diseases: Possible role of estrogenic compounds [J].
Ahmed, SA ;
Hissong, BD ;
Verthelyi, D ;
Donner, K ;
Becker, K ;
Karpuzoglu-Sahin, E .
ENVIRONMENTAL HEALTH PERSPECTIVES, 1999, 107 :681-686
[3]   DECREASED PRODUCTION OF AND RESPONSE TO INTERLEUKIN-2 BY CULTURED LYMPHOCYTES FROM PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
ALCOCERVARELA, J ;
ALARCONSEGOVIA, D .
JOURNAL OF CLINICAL INVESTIGATION, 1982, 69 (06) :1388-1392
[4]   COMPLEMENT ACTIVATION AND COMPLEMENT RECEPTORS IN SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
ATKINSON, JP .
SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 1986, 9 (2-3) :179-194
[5]   LYMPHOCYTE-T SUBSETS IN SYSTEMIC LUPUS-ERYTHEMATOSUS - CORRELATIONS WITH CORTICOSTEROID-THERAPY AND DISEASE-ACTIVITY [J].
BAKKE, AC ;
KIRKLAND, PA ;
KITRIDOU, RC ;
QUISMORIO, FP ;
REA, T ;
EHRESMANN, GR ;
HORWITZ, DA .
ARTHRITIS AND RHEUMATISM, 1983, 26 (06) :745-750
[6]  
Baumann I, 2002, ARTHRITIS RHEUM-US, V46, P191, DOI 10.1002/1529-0131(200201)46:1<191::AID-ART10027>3.0.CO
[7]  
2-K
[8]   THE IMMUNOLOGY OF PROLACTIN [J].
BERCZI, I .
SEMINARS IN REPRODUCTIVE ENDOCRINOLOGY, 1992, 10 (03) :196-219
[9]   PREVENTION OF RELAPSES IN SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
BOOTSMA, H ;
SPRONK, P ;
DERKSEN, R ;
DEBOER, G ;
WOLTERSDICKE, H ;
HERMANS, J ;
LIMBURG, P ;
GMELIGMEYLING, F ;
KATER, L ;
KALLENBERG, C .
LANCET, 1995, 345 (8965) :1595-1599
[10]   Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies [J].
Botto, M ;
Dell'Agnola, C ;
Bygrave, AE ;
Thompson, EM ;
Cook, HT ;
Petry, F ;
Loos, M ;
Pandolfi, PP ;
Walport, MJ .
NATURE GENETICS, 1998, 19 (01) :56-59